Evidence map›Paper›PMID 42088113›Full record

ArticleThe journal of liquid biopsy2026

Exploring tear biomarkers with shotgun proteomics for retinoblastoma diagnosis: a pilot study.

Andrés Rodríguez-Rodríguez, Karla Grisel Calderón-González, Juan Pedro Luna-Arias, Mariana Moctezuma-Dávila, Martha Rangel-Charqueño, Bernardo Yañez-Soto, Vanesa Olivares-Illana, Jesús Hernández-Monge

Abstract read
In one paragraph

Article in The journal of liquid biopsy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Andrés Rodríguez-RodríguezLaboratorio de Interacciones Biomoleculares y Cáncer, Instituto de Física, Universidad Autónoma de San Luis Potosí, Mexico.
Karla Grisel Calderón-GonzálezLaboratorio de Interacciones Biomoleculares y Cáncer, Instituto de Física, Universidad Autónoma de San Luis Potosí, Mexico.
Juan Pedro Luna-AriasDepartamento de Biología Celular, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional (Cinvestav-IPN), Av. Instituto Politécnico Nacional 2508, Col. San Pedro Zacatenco, Gustavo A. Madero, C.P. 07360, Ciudad de México, Mexico.
Mariana Moctezuma-DávilaOphthalmic pathology Fellow at Houston Methodist Hospital, USA.
Martha Rangel-CharqueñoDepartamento de Oftalmologıa, Hospital Central "Ignacio Morones Prieto", San Luis Potosí, Mexico.
Bernardo Yañez-SotoInvestigador por México SECIHTI- Laboratorio de Biomarcadores Moleculares, Instituto de Física, Universidad Autónoma de San Luis Potosí, Mexico.
Vanesa Olivares-IllanaLaboratorio de Interacciones Biomoleculares y Cáncer, Instituto de Física, Universidad Autónoma de San Luis Potosí, Mexico.
Jesús Hernández-MongeInvestigador por México SECIHTI- Instituto de Física, Universidad Autónoma de San Luis Potosí, Mexico.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The most common ocular neoplasia among children is retinoblastoma. Currently, the diagnosis of this disease is essentially clinical, taking a biopsy is contraindicated owing to the high risk of causing metastasis. Therefore, it is imperative the development of a method to diagnose this disease through a non-invasive fashion. We choose tears as they fulfill the former precept. Through proteomic analysis we observed 52 up regulated and 48 down regulated proteins among retinoblastoma cases as compared to healthy children. Among these proteins, we identified several previously associated with retinoblastoma such as apolipoprotein A-1 (

Indexed as

BiomarkersProteomeRetinoblastomaTears

Identifiers

PMID42088113
PMCPMC13137024

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.